3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
11
Burkitt Lymphoma
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Smoldering Multiple Myeloma
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Neoplasms
1
Neoplasm Metastasis
1
Leukemia, Plasma Cell
1
Leukemia, Biphenotypic, Acute
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
Temozolomide
23
Radiotherapy
10
Magnetic Resonance Spectroscopy
10
Radiation
8
Specimen Handling
7
Lomustine
4
Bevacizumab
4
Nivolumab
3
Biopsy
3
veliparib
2
trametinib
2
olaparib
2
lutetium Lu 177 dotatate
2
dabrafenib
2
cemiplimab
2
azeliragon
2
Surgical Procedures, Operative
2
Receptors, Interleukin-8B
2
Photons
2
Palliative Care
2
Ipilimumab
2
D2C7-(scdsFv)-PE38KDEL
2
CTLA-4 Antigen
2
Aminolevulinic Acid
2
vocimagene amiretrorepvec
1
varlilumab
1
ulixertinib
1
tinostamustine
1
temsirolimus
1
senicapoc
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
dexamethasone acetate
×
30 days
×
Clear all
No trials found.